Discover Syntara’s latest Phase 2a trial results for amsulostat in myelofibrosis, showing breakthrough symptom relief and strong pipeline updates.
Syntara Limited ( OTCPK:PMXSF) Shareholder/Analyst Call September 29, 2025 9:00 PM EDT ...
Orlando Outlet Marketplace stands as a shopper’s utopia in the bustling heart of Florida’s tourism mecca, where high-end fashion meets wallet-friendly reality. Have you ever experienced that rush of ...
When biomedical researchers need to test their latest ideas, they often turn to engineered human tissue that mimics the ...
The key to adhering to the original intention of 'making good cars' and gaining high recognition from the automotive market ...
The deubiquitinase USP17LA negatively regulates T-cell activation and attenuates anti-tumor immunity
USP17LA loss enhances T-cell function and anti-tumor activity in murine tumor models. Usp17la-deficient T cells exhibit ...
The Chinese automotive market in 2025 is at a critical stage where the reform of the new energy and fuel markets is entering ...
Research Progress of 3D Printing Combined with Virtual Reality Technology in Medical Education Practice: A Bibliometric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback